← Open Payments lookup

TAJUDEEN KOLAWOLE: Open Payments

NPI 1861091191 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,538 in 132 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $628 · 2025 $2,538

Food & beverage: $2,538
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.40$654
Neurocrine BioSciences, Inc.16$464
Alkermes, Inc.29$363
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$238
E.R. Squibb & Sons, L.L.C.8$226
Vanda Pharmaceuticals Inc.6$188
ABBVIE INC.11$153
Janssen Pharmaceuticals, Inc4$118
Otsuka America Pharmaceutical, Inc.4$87
Lundbeck LLC2$47

Products named: INGREZZA, UZEDY, ARISTADA, CAPLYTA, AUSTEDO XR, COBENFY, FANAPT, VRAYLAR.

Industry payments across PA — which companies pay providers there.